Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Lin B, Lu Y, Huang JF, Gong Y, Liu HH, Liu XL, Tian MY, Zhou Y, Yuan WC. Et₂NH catalysis-enabled construction of convolutamydine A-fused morusignin L-scaffolds and their biological evaluation for anticancer activities. SYNTHETIC COMMUN 2017. [DOI: 10.1080/00397911.2016.1277246] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]

For:	Lin B, Lu Y, Huang JF, Gong Y, Liu HH, Liu XL, Tian MY, Zhou Y, Yuan WC. Et₂NH catalysis-enabled construction of convolutamydine A-fused morusignin L-scaffolds and their biological evaluation for anticancer activities. SYNTHETIC COMMUN 2017. [DOI: 10.1080/00397911.2016.1277246] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]

Number

Cited by Other Article(s)

Liu XW, Yang J, Wang GL, Gong Y, Feng TT, Liu XL, Cao Y, Zhou Y, Yuan WC. Molecular Hybridization-Guided Construction of Convolutamydine A-fused β -Ionone Scaffolds and their Biological Evaluation for Anticancer Activities. J Heterocycl Chem 2017. [DOI: 10.1002/jhet.3027] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]